AbbVie | ABBV - Stock

Aktienkurs
210.97
Täglich Wechseln
-0.62 -0.29%
Monatlich
-7.07%
Jährlich
21.11%
Q2 Prognose
202.55




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Abbott USD 6.49B 220M 2025-12
ALKERMES USD 196.62M 5.63M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
Biogen USD 2.17B 41.3M 2025-12
BioMarin Pharmaceutical USD 1.3B 83.29M 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Coherus Biosciences USD 3.17M 1.12M 2025-12
Eisai JPY 236.46B 9.14B 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
Gilead Sciences USD 1.78B 40M 2025-09
GlaxoSmithKline GBP 6.12B 46M 2025-09
Infinity Pharmaceuticals USD 0 0 2021-09
J&J USD 14.19B 45M 2025-12
Medtronic USD 6.31B 153M 2025-12
Merck USD 6.44B 157M 2025-09
Neurocrine Biosciences USD 69M 300K 2025-12
Novartis USD 6.42B 114M 2025-09
Pacira USD 152.86M 4.82M 2025-12
Perrigo USD 1.15B 78M 2025-12
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Sanofi EUR 22.69B 1.81B 2025-12
UCB EUR 1.31B 173M 2024-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09
United Therapeutics USD 183.1M 6.6M 2025-12
Vertex Pharmaceuticals USD 1.69B 60M 2025-12
Zoetis USD 2.43B 35M 2025-12